Jun 23, 2026 08:03AM
Jun 23, 2026 08:00AM
Jun 2, 2026 08:01AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
May 15, 2026 08:00AM INmune Bio publishes phase 2 alzheimer's trial results in peer journal
May 15, 2026 08:00AM
May 15, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 13, 2026 08:00AM INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
May 7, 2026 04:00PM
May 5, 2026 04:00PM
May 5, 2026 04:00PM
Apr 30, 2026 08:00AM
Apr 16, 2026 11:42AM
Apr 16, 2026 08:00AM
Apr 16, 2026 08:00AM INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models
Apr 16, 2026 08:00AM
Mar 30, 2026 04:00PM
Mar 30, 2026 04:00PM
Mar 24, 2026 08:00AM
Mar 19, 2026 08:00AM
Feb 23, 2026 09:25AM
Feb 19, 2026 12:16PM INmune Bio to host webinar on RDEB treatment data
Feb 19, 2026 12:15PM
Feb 12, 2026 07:01AM
Feb 12, 2026 07:00AM
Feb 10, 2026 08:04AM
Feb 10, 2026 08:00AM
Jan 27, 2026 09:25AM
Jan 27, 2026 09:25AM INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives
Dec 5, 2025 07:00AM
Dec 1, 2025 08:03AM
Dec 1, 2025 08:00AM
Dec 1, 2025 08:00AM
Dec 1, 2025 08:00AM
Nov 18, 2025 08:00AM
Oct 30, 2025 04:05PM INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
Oct 23, 2025 07:00AM
Oct 14, 2025 07:00AM
Sep 29, 2025 08:01AM
Sep 29, 2025 08:00AM
Sep 15, 2025 08:00AM
Aug 7, 2025 04:06PM
Aug 7, 2025 04:05PM INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes
Aug 4, 2025 08:14AM

323,995 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All